Fertility preservation and reproductive counseling in women with hereditary gynecological cancer predisposition: A scoping review of BRCA1/2 and Lynch syndrome care pathways

Abstract Objective This study maps the evidence on fertility preservation, reproductive counseling, contraception, hormone replacement therapy (HRT) and care pathway integration for women with hereditary gynecological cancer predisposition, principally breast cancer genes 1 and 2 (BRCA1 and BRCA2) and Lynch syndrome, and derives a clinical decision‐making framework. Methods A scoping review was conducted following the Joanna Briggs Institute methodology and PRISMA extension for scoping reviews (PRISMA‐ScR). The core search covered seven databases, Google Scholar and 11 gray literature sources from January 2000 to June 2025; a targeted supplementary search of MEDLINE and Embase for contraception and HRT was run to 7 October 2026 in response to peer review. Records from both searches were combined for selection. Two reviewers screened records and charted data, and findings were synthesized narratively. Results Of 5113 records identified, 4273 were screened after de‐duplication, 280 were assessed in full, and 99 sources were included. Evidence came mainly from high‐income countries and concerned BRCA1/2 carriers; 12 sources focused on Lynch syndrome. Oocyte and embryo cryopreservation were feasible, but live‐birth outcomes were rarely reported. Oral contraception was associated with lower ovarian cancer risk and, in BRCA1 carriers, a modest increase in breast cancer risk with longer use. HRT after premenopausal risk‐reducing salpingo‐oophorectomy was not associated with increased breast cancer risk in women without breast cancer yet remained underused. Counseling content and timing were inconsistent, and evidence for Lynch syndrome, low‐ and middle‐income countries, and minority ethnic populations was sparse. Conclusion Reproductive counseling covering fertility preservation, preimplantation genetic testing, contraception, and HRT should begin at genetic diagnosis and precede irreversible surgery. The proposed 10‐step framework requires prospective evaluation.

Authors

Institutions

Publication Details

Journal
International Journal of Gynecology & Obstetrics
Published
2026-11-14
DOI
https://doi.org/10.1002/ijgo.71494
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fertility preservation and reproductive counseling in women with hereditary gynecological cancer predisposition: A scoping review of BRCA1/2 and Lynch syndrome care pathways

Rana Mondal, Mouli Nandi
International Journal of Gynecology & Obstetrics
BRCA gene mutations in cancer
article

Fertility preservation and reproductive counseling in women with hereditary gynecological cancer predisposition: A scoping review of BRCA1/2 and Lynch syndrome care pathways

Rana Mondal, Mouli Nandi
article en

Abstract

Abstract Objective This study maps the evidence on fertility preservation, reproductive counseling, contraception, hormone replacement therapy (HRT) and care pathway integration for women with hereditary gynecological cancer predisposition, principally breast cancer genes 1 and 2 (BRCA1 and BRCA2) and Lynch syndrome, and derives a clinical decision‐making framework. Methods A scoping review was conducted following the Joanna Briggs Institute methodology and PRISMA extension for scoping reviews (PRISMA‐ScR). The core search covered seven databases, Google Scholar and 11 gray literature sources from January 2000 to June 2025; a targeted supplementary search of MEDLINE and Embase for contraception and HRT was run to 7 October 2026 in response to peer review. Records from both searches were combined for selection. Two reviewers screened records and charted data, and findings were synthesized narratively. Results Of 5113 records identified, 4273 were screened after de‐duplication, 280 were assessed in full, and 99 sources were included. Evidence came mainly from high‐income countries and concerned BRCA1/2 carriers; 12 sources focused on Lynch syndrome. Oocyte and embryo cryopreservation were feasible, but live‐birth outcomes were rarely reported. Oral contraception was associated with lower ovarian cancer risk and, in BRCA1 carriers, a modest increase in breast cancer risk with longer use. HRT after premenopausal risk‐reducing salpingo‐oophorectomy was not associated with increased breast cancer risk in women without breast cancer yet remained underused. Counseling content and timing were inconsistent, and evidence for Lynch syndrome, low‐ and middle‐income countries, and minority ethnic populations was sparse. Conclusion Reproductive counseling covering fertility preservation, preimplantation genetic testing, contraception, and HRT should begin at genetic diagnosis and precede irreversible surgery. The proposed 10‐step framework requires prospective evaluation.

International Journal of Gynecology & Obstetrics
Luton and Dunstable University Hospital NHS Foundation Trust (GB)
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon